IL36G and psoriasis: For the differentiation of AD and psoriasis, studies have shown that the expression of interleukin (IL)-36γ (IL-1F9) in the skin lesions of patients with psoriasis is significantly increased, which can be used to distinguish between AD and psoriasis (22).